Allion Healthcare, Inc. Announces Pricing Of Public Offering Of Common Stock

MELVILLE, N.Y., Jan. 26 /PRNewswire-FirstCall/ -- Allion Healthcare, Inc. , a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients, today announced the pricing of a public offering of 4,436,454 shares of common stock at $12.83 per share. Of the total shares, the Company is offering 1,800,000 shares of common stock and 2,636,454 shares are being offered by certain selling stockholders. The Company will receive gross proceeds of $21,823,830 from the primary shares offered by it and will not receive any proceeds from the sale of shares by selling stockholders. The Company expects to complete the sale of these shares on or about January 31, 2006, subject to customary closing conditions.

In connection with the offering, the Company has granted the underwriters a 30-day option to purchase an additional 665,468 shares to cover over- allotments, if any.

The offering was underwritten by Thomas Weisel Partners LLC, as sole book manager, and William Blair & Company, First Albany Capital and Susquehanna Financial Group, LLLP, as co-managers. When available, a final prospectus related to the offering may be obtained by contacting: Thomas Weisel Partners LLC, One Montgomery Street, Suite 3700, San Francisco, California 94104, Attn: Syndicate Desk (Tel.: (415) 364-2720, Fax: (415) 364-2799); William Blair & Company, L.L.C., 222 West Adams Street, Chicago, Illinois 60606, Attn: Syndicate Desk (Tel.: (312) 364-8990); First Albany Capital Inc., One Penn Plaza, 42nd Floor, New York, New York 10119, Attn: Syndicate Desk (Tel.: (212) 273-7100); or Susquehanna Financial Group, LLLP, 401 E. City Avenue, Suite 220, Bala Cynwyd, PA, 19004, Attn: Equity Capital Markets (Tel.: (610) 747-2536).

A registration statement relating to these securities was filed with and declared effective by the Securities and Exchange Commission. The public offering is being made by means of a prospectus. This press release shall not constitute an offer to sell or the solicitation of an offer to buy common stock of Allion Healthcare, Inc., nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification of the securities under the securities laws of any such state or jurisdiction.

About Allion Healthcare, Inc.

Allion Healthcare, Inc. is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under the trade name MOMS Pharmacy. Allion Healthcare works closely with physicians, nurses, clinics and AIDS Service Organizations, and with government and private payors, to improve clinical outcomes and reduce treatment costs for its patients. Most of Allion Healthcare's patients rely on Medicaid and other state-administered programs, such as the AIDS Drug Assistance Program, to pay for their HIV/AIDS medications.

Contact: Allion Healthcare, Inc. Jim Spencer, Chief Financial Officer (631) 870-5126 The Ruth Group Francesca DeMartino, Investor Relations (646) 536-7024, fdemartino@theruthgroup.com

Allion Healthcare, Inc.

CONTACT: Jim Spencer, Chief Financial Officer, Allion Healthcare, Inc.,+1-631-870-5126; or Investors: Francesca DeMartino of The Ruth Group forAllion Healthcare, Inc., +1-646-536-7024, fdemartino@theruthgroup.com

MORE ON THIS TOPIC